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▼Raising polyclonal antibodies is an indispensable tool in
today’s biomedical research. Animals commonly used to
produce antisera include rabbits, rats, guinea pigs, chicken
and hamsters. When mice are used, the polyclonal anti-
bodies are usually produced in ascites fluid, which some-
times results in low yield and specificity and also causes
distress to the animal. Nevertheless, mice are an ideal
animal system for this purpose as they are easily main-
tained at a low cost in an animal facility, require a small
amount of immunogen and antibodies can be obtained
within a short period. Although detailed methodologies
have been published for raising antibodies in mouse as-
cites (Ref. 1, 2), we have been unable to find a detailed
protocol on raising polyclonal antibodies in mouse serum,
as is often done in rabbits. Using rabbits requires a large
amount of immunogen, takes a much longer period and is
expensive.
We report on a quick and inexpensive protocol for rais-
ing high specificity antibodies in mice. We have raised
polyclonal antibodies to a bacterially expressed fusion pro-
tein in mice in just 5 weeks. The antibodies showed no
cross-reactivity to other bacterial proteins by western blot
analysis. They were used successfully without purification
in indirect immunohistochemistry and western blot. The
novelty of this technique is that it produces high quality
antibodies with and without the use of complete Freund’s
adjuvant (CFA) in a cost-effective manner. The generation
of antibodies without CFA is a more ‘animal friendly’ pro-
tocol that is acceptable to most Institutional Animal Care
and Use Committees (IACUC).
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We believe that the protocol that is described here would
be useful to other researchers and therefore should be made
available to them. To our knowledge, this is the first pro-
tocol that provides details on the immunization schedule
and amount of protein that can be easily used to raise high
specificity antibodies in mice within a short period, with
and without CFA.
Protocol
Bacterial expression, identification and solubilization of cmf1
protein for antibody production
CMF1 is a molecule that is isolated from the stage
11 chicken embryo (Ref. 3). We cloned a por-
tion of this cDNA in frame (4195–5469 bp)
into an expression vector, pET 29b (Novagen
Inc.; 69875-3). This piece encoded a protein of
∼50 kDa. Protein expression and purification was
performed as described in the pET instruction
manual.
Bacterially expressed CMF1 (insoluble fraction) was sepa-
rated by 10% SDS-PAGE and the band excised. The
identity of the protein was confirmed using mass spec-
trometry. The gel band that contained the protein was
homogenized in the presence of liquid nitrogen and
mixed with (1:1) Freund’s adjuvant (complete or in-
complete) and injected (multiple sites) sub-cutaneously
(s.c.) in 3–4 week old BALB/c mice (Charles River Lab-
oratories) as per the immunization schedule (Table 1).
Serum collection and storage
All bleeds were through the retro-orbital plexus, except for
the final bleed, which was by decapitation. Approx-
imately 250 µl blood was collected from the retro-
orbital plexus of each mouse in an equal volume of
1 × phosphate buffered saline (PBS) and allowed to
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Table 1. Immunization schedule
Mice 1–5 Mouse 6a
Day 0 Pre bleed Pre bleed
First injectionb 100 µg 500 µg
Day 14 Second injection 100 µg 500 µg
Day 28 Third injection 100 µg 500 µg
Day 35 First bleed First bleed
Day 42 Final bleed Final bleed
aNo adjuvant was used in this mouse, either complete or
incomplete. bThe first injection was with complete
Freund’s adjuvant. All subsequent injections were with
incomplete Freund’s adjuvant.
clot at 4◦C overnight. Tubes were centrifuged and the
clear serum was aliquoted and frozen at −20◦C. The
final bleed that was obtained by decapitation yielded
approximately 1.5 ml of blood per mouse, which was
processed as above and the serum stored at −20◦C.
Characterization of the serum by western blot analysis
The insoluble fraction containing the bacterially expressed
CMF1 was separated by SDS-PAGE, transferred to a
nitrocellulose membrane and probed with the serum
from the six different (pre-immune and immune) ani-
mals.
Goat anti-mouse antibody tagged with horseradish peroxi-
dase (Pierce; 31430ZZ) was used as the secondary anti-
body. The western blot was developed using the Super-
Signal West Pico Chemiluminescent Substrate (Pierce;
34080).
The protein fraction was also probed with antibodies (No-
vagen; 69047-3) directed against S-Tag peptide. (The
bacterially expressed protein is a fusion protein of S-
Tag and CMF1.) This served as a control to identify the
presence of the CMF1 fusion protein. The SDS-PAGE gel
was stained with gel code blue stain (Pierce; 1856170)
for visualization of the total protein profile (Fig. 1).
Immunofluorescence studies using the polyclonal serum
Dog fibroblasts (D17 2G) transfected with a CMF1 sense
construct (CXL RE 7) and antisense construct (CXL
RE 9) were used. The cells were grown in 35 mm
culture dishes in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing 10% fetal calf serum (FCS) and 1%
penicillin-streptomycin.
The cells were then fixed in 100%methanol, blocked in the
presence of 10% goat serum and incubated with im-
mune serum at a 1:100 dilution in 1× PBS. Fluorescein-
tagged goat anti-mouse IgG was used as the second
antibody. Washes were in 1 × PBS containing 0.05%
Tween-20. Controls were incubated in the absence of
the primary antibody.
FIGURE 1. 10% SDS-PAGE Gel stained with gel code blue stain. Lane
1 shows the molecular weight (MW) markers; lanes 2–4 show the total,
soluble and insoluble protein fractions, respectively. The bacterially
expressed CMF1 fusion protein is marked with an arrow. Note the high
amounts of bacterially expressed CMF1 fusion protein in the insoluble
fraction.
In the western blot analysis of the antiserum, the pre-
immune sera did not cross-react with any of the pro-
teins loaded (Fig. 2a). The immune sera from all of the six
mice recognized the bacterially expressed protein with high
specificity and strong intensity. No other bacterial protein
showed cross-reactivity to the antiserum (Fig. 2b). Thus the
polyclonal serum that was raised was of high specificity and
did not require purification. Because the band intensity was
high, we found that we could use higher dilutions of the
serum, thereby conserving the antibody and making this
procedure economical. We have found that 1 µl of the an-
tiserum that is blotted on a membrane shows a very strong
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FIGURE 2. (a) Western blot analysis using the pre-immune sera from 6 different mice (M1–M6). The insoluble protein fraction was probed separately
with pre-immune sera (1:100 dilution) from all 6 mice. No cross-reactivity was seen in all the six sera tested. The control lane (C), probed with S-Tag
antibodies (1:5000 dilution) shows the ∼50 kDa bacterially expressed CMF1 fusion protein. (b) Western blot analysis using the immune sera (1:100
dilution) from 6 different mice (M1–M6). The blot shows high cross-reactivity with the bacterially expressed CMF1 fusion protein against all six sera
tested. A lower band is also seen, which corresponds to a truncated CMF1 fusion protein product.
FIGURE 3. Immunofluorescence staining of D17 2G dog fibroblasts, transfected with the sense construct of CMF1 (CXL RE 7). The cells were
incubated in the presence of the immune serum (1:100 dilution), followed by fluorescein-tagged goat anti-mouse IgG as the second antibody. The staining
is localized to the cytoplasm (a and c) as well as to the nucleus (b) of the transfected fibroblasts.
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signal when probed with a 1:120 000 dilution of secondary
antibody (A.R. Redkar and J. Litvin, unpublished).
Because bacterially expressed CMF1 is a fusion peptide of
S-Tag and CMF1, antibodies against S-Tag serve as a control,
identifying the presence of the CMF1 fusion protein in the
insoluble protein fraction. The control lane (Figure 2a) was
probed with antibodies against S-Tag peptide, which shows
a single band of ∼50 kDa.
In addition to the western blot, we tested the sera in
immunofluorescence studies. Two stably transfected (non-
synchronous) cell lines that expressed CMF1 in sense (CXL
RE 7) and antisense (CXL RE 9) were used in these studies.
The antisera specifically stained the CXL RE 7 (Figure 3)
cells and not the CXL RE 9 cells (data not shown). The
staining was cytoplasmic (Figure 3a, c) as well as nuclear
(Figure 3b), which agrees with the presence of a nuclear
localization sequence (NLS) in the CMF1 protein.
In conclusion, we were able to successfully raise poly-
clonal antibodies with high specificity in mice, which
worked in both western blotting as well as immunostain-
ing procedures. The technique is economical, fast and easy
and can be achieved with or without the use of CFA; al-
though this might vary according to the type of antigen.
Therefore, in today’s biomedical research endeavors where
time and money are of an essence, our protocol will help
efficiently raise high quality antibodies in mice in a short
period.
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Products Used
expression vector pET19b: expression vector
pET19b from Novagen
BALB/cmice: BALB/cmice fromCharles River Lab-
oratories
horseradish peroxidase: horseradish peroxidase
from Pierce
SuperSignal chemiluminescence kit: SuperSig-
nal chemiluminescence kit from Pierce
antibodies: antibodies from Sigma
antibodies: antibodies from Amresco Inc
Gel Code Blue: Gel Code Blue from Pierce
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